Skip to main content
    M

    MEDIFAST INC (MED)

    Official site

    CONSUMER CYCLICAL • PERSONAL SERVICES • NYSE

    $12.22
    -0.32 (-2.51%)

    Market Cap: $140.23M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    MEDIFAST INC (MED) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    MEDIFAST INC (MED) has a market cap of $140.23M and an enterprise value of $99.47M. Revenue fell 30.28% over the last 12 months from the 12 months before. It holds $40.76M more cash than debt, 29.07% of its market cap.

    Total Valuation

    Enterprise value is 29.07% below the market cap, as cash exceeds debt.

    Market Cap$140.23M
    Enterprise Value$99.47M
    Latest price (Nov 17, 2026)$12.22

    Key Dates

    The next earnings report is expected on Feb 15, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 15, 2027 (expected)
    Last Earnings DateOct 26, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.41% in the quarter ended Sep 30, 2026 and grew 1.11% a year over 2 years.

    Shares Outstanding11.18M
    Shares Change (YoY)+1.73%
    Shares Change (QoQ)+0.41%
    Share Count Growth (2Y CAGR)+1.11%

    Valuation Ratios

    Sales and book value multiples are 0.5x and 0.8x. Its year-end P/S ranged from 0.3x to 3.0x from 2016 to 2025.

    P/S Ratio0.5x
    Forward P/S0.5x
    P/B Ratio0.8x

    Valuation history and multiples

    Price Statistics

    The stock is up 7.43% over 52 weeks and trades 0.74% above its 50-day average.

    Beta (1Y)1.14
    52-Week Change+7.43%
    1-Month Change+1.62%
    3-Month Change+5.57%
    6-Month Change-2.90%
    5-Year Change-93.81%
    10-Year Change-70.41%
    Total Return (1Y)+7.43%
    Total Return (3Y CAGR)-43.13%
    Total Return (5Y CAGR)-42.61%
    Return vs SPY (1Y)-2.21%
    Max Drawdown (1Y)-28.14%
    Max Drawdown (3Y)-87.47%
    Sharpe Ratio (1Y)0.18
    Correlation with SPY (1Y)0.31
    50-Day Average$12.13
    200-Day Average$11.39
    52-Week Range$9.22 to $13.63
    RSI (14 Days)46.1
    Average Volume (20 Days)135.86K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 4.82x current liabilities, and total debt is 0.10x shareholder equity.

    Current Ratio4.82x
    Quick Ratio4.32x
    Debt / Equity0.10x

    Returns and Efficiency

    Return on invested capital is -17.59% over the last 12 months, against a 5-year average of 13.02%.

    Return on Equity (ROE)-22.66%
    Return on Assets (ROA)-17.04%
    Return on Invested Capital (ROIC)-17.59%
    ROE (5Y Average)42.91%
    ROA (5Y Average)22.37%
    ROIC (5Y Average)13.02%
    Asset Turnover1.18x
    Inventory Turnover4.35x

    Scores

    MED has an Altman Z-Score of 3.74, in the safe zone above 2.99, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score3.74
    Altman Z ZoneSafe
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $299.57M over the last 12 months.

    Revenue$299.57M
    Revenue Growth (YoY)-30.28%
    Gross Profit$207.33M
    Operating Income-$34.78M
    Pretax Income-$29.15M
    Net Income-$40.85M
    EBITDA-$22.67M
    Reported EPS (TTM)-$2.31

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 75.19% of the $239.76M in total assets.

    Cash and Equivalents$58.37M
    Total Debt$17.61M
    Net Cash$40.76M
    Net Cash Per Share$3.65
    Working Capital$160.06M
    Shareholder Equity$180.28M
    Book Value Per Share$16.12
    Total Assets$239.76M
    Total Liabilities$59.49M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $3.84M of capital spending, operating cash flow left -$3.87M of free cash flow.

    Operating Cash Flow-$26.00K
    Capital Expenditures$3.84M
    Free Cash Flow-$3.87M
    FCF Per Share-$0.35
    Depreciation and Amortization$13.38M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -11.61%, against a 5-year average of 6.86%.

    Gross Margin69.21%
    Operating Margin-11.61%
    Pretax Margin-9.73%
    Net Margin-13.64%
    EBITDA Margin-7.57%
    FCF Margin-1.29%
    Gross Margin (5Y Average)72.55%
    Operating Margin (5Y Average)6.86%
    Net Margin (5Y Average)4.90%

    Growth

    Revenue fell 37.74% a year over 3 years.

    Revenue Growth (3Y CAGR)-37.74%
    Revenue Growth (5Y CAGR)-16.22%
    FCF Growth (3Y CAGR)-80.85%
    FCF Growth (5Y CAGR)-61.05%
    Book Value Per Share Growth (2Y CAGR)-0.89%
    Tangible Book Per Share Growth (2Y CAGR)-0.89%

    Revenue and profit by year

    Dividends and Yields

    MED does not pay a dividend. Its free cash flow yield is -2.83%.

    FCF Yield-2.83%
    Buyback Yield0.60%

    Peer Position

    Against 8 similar companies, MED has the 6th highest P/S and the 7th highest ROIC.

    P/S Ratio0.5x vs 0.7x median
    ROIC-17.59% vs 5.99% median
    Revenue Growth (Trailing 4 Quarters, YoY)-30.28% vs -8.64% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -15.65% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-15.65%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About MED

    What is MED's market cap?

    MEDIFAST INC has a market cap of $140.23M. Its enterprise value, which adds debt and subtracts cash, is $99.47M.

    How many shares of MED are outstanding?

    MEDIFAST INC has 11.18M shares outstanding. The count is up 1.73% from a year earlier.

    Does MED pay a dividend?

    No. MEDIFAST INC does not pay a dividend.

    How much debt does MED have?

    MEDIFAST INC has $17.61M of total debt and $58.37M of cash and equivalents, a net cash position of $40.76M.